• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对美国非间质性肺疾病中心的肺科医生进行的横断面调查。

A Cross-Sectional Survey of Pulmonologists Working at Non-ILD Centers in the United States.

作者信息

Biehl Rodney, Jeganathan Niranjan, Imperio Michelle, Becerra Benjamin J, López David, Alismail Abdullah

机构信息

Department of Cardiopulmonary Sciences, School of Allied Health Professions, Loma Linda University, Loma Linda, CA, USA.

Department of Pulmonary and Critical Care Medicine, Loma Linda University Health, Loma Linda, CA, USA.

出版信息

J Multidiscip Healthc. 2023 Jul 14;16:1939-1942. doi: 10.2147/JMDH.S421089. eCollection 2023.

DOI:10.2147/JMDH.S421089
PMID:37469669
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10353560/
Abstract

The purpose of this cross-sectional short report study was to evaluate the perception of pulmonologist working in noninterstitial lung disease centers on challenges (COE) encountered in daily practice. Results of this survey revealed that only 40% of their patients are referred to an ILD COE, out of 69% who have access to an ILDCOE. Of these patients who were referred, the perceived benefits were rated high when it comes to having an accurate diagnosis.

摘要

本横断面简短报告研究的目的是评估在非间质性肺病中心工作的肺科医生对日常实践中遇到的挑战(卓越中心)的看法。该调查结果显示,在有机会前往间质性肺病卓越中心的患者中,只有40%的患者被转诊至此类中心。在这些被转诊的患者中,就获得准确诊断而言,他们所感知到的益处被评为很高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/076b/10353560/bf3fd3f5b4a8/JMDH-16-1939-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/076b/10353560/bf3fd3f5b4a8/JMDH-16-1939-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/076b/10353560/bf3fd3f5b4a8/JMDH-16-1939-g0001.jpg

相似文献

1
A Cross-Sectional Survey of Pulmonologists Working at Non-ILD Centers in the United States.对美国非间质性肺疾病中心的肺科医生进行的横断面调查。
J Multidiscip Healthc. 2023 Jul 14;16:1939-1942. doi: 10.2147/JMDH.S421089. eCollection 2023.
2
Genetic testing in interstitial lung disease: An international survey.遗传性肺间质疾病的基因检测:一项国际调查。
Respirology. 2022 Sep;27(9):747-757. doi: 10.1111/resp.14303. Epub 2022 Jun 2.
3
Translating Idiopathic pulmonary fibrosis guidelines into clinical practice.将特发性肺纤维化指南转化为临床实践。
Pulmonology. 2021 Jan-Feb;27(1):7-13. doi: 10.1016/j.pulmoe.2020.05.017. Epub 2020 Jun 16.
4
Impact of an interstitial lung disease service in the diagnosis and management of interstitial lung disease in Singapore.新加坡间质性肺病服务对间质性肺病诊断和管理的影响。
Singapore Med J. 2020 Jun;61(6):302-307. doi: 10.11622/smedj.2019069. Epub 2019 Jul 11.
5
Role of a Regional Multidisciplinary Conference in the Diagnosis of Interstitial Lung Disease.区域性多学科会议在间质性肺疾病诊断中的作用。
Ann Am Thorac Soc. 2019 Apr;16(4):455-462. doi: 10.1513/AnnalsATS.201811-794OC.
6
Interpretation of HRCT Scans in the Diagnosis of IPF: Improving Communication Between Pulmonologists and Radiologists.特发性肺纤维化(IPF)的 HRCT 扫描解读:加强肺病学家与放射科医生之间的沟通。
Lung. 2018 Oct;196(5):561-567. doi: 10.1007/s00408-018-0143-5. Epub 2018 Aug 10.
7
Healthcare Resources Utilization and Costs of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease Based on Insurance Claims in the USA.基于美国保险索赔数据的非特发性肺纤维化进行性纤维化性间质性肺疾病患者的医疗资源利用和费用。
Adv Ther. 2020 Jul;37(7):3292-3298. doi: 10.1007/s12325-020-01380-4. Epub 2020 May 21.
8
The Role of Surgical Lung Biopsy in the Diagnosis of Fibrotic Interstitial Lung Disease: Perspective from the Pulmonary Fibrosis Foundation.外科肺活检在纤维化间质性肺疾病诊断中的作用:来自肺纤维化基金会的观点
Ann Am Thorac Soc. 2021 Oct;18(10):1601-1609. doi: 10.1513/AnnalsATS.202009-1179FR.
9
The Impact of Multidisciplinary Discussion (MDD) in the Diagnosis and Management of Fibrotic Interstitial Lung Diseases.多学科讨论(MDD)对纤维化间质性肺疾病的诊断和管理的影响。
Can Respir J. 2020 Aug 15;2020:9026171. doi: 10.1155/2020/9026171. eCollection 2020.
10
Challenges in the diagnosis of idiopathic pulmonary fibrosis: the importance of a multidisciplinary approach.特发性肺纤维化的诊断挑战:多学科方法的重要性。
Expert Rev Respir Med. 2023 Apr;17(4):1-11. doi: 10.1080/17476348.2023.2199156. Epub 2023 Apr 26.

引用本文的文献

1
Person-centred health outcomes in the routine care for people with progressive pulmonary fibrosis: the COCOS-IPF project's European survey on healthcare professionals' views and practices.进行性肺纤维化患者常规护理中的以患者为中心的健康结局:COCOS-IPF项目关于医疗保健专业人员观点和实践的欧洲调查
Respir Res. 2025 Feb 28;26(1):81. doi: 10.1186/s12931-025-03146-4.

本文引用的文献

1
Comparing outcomes of ILD patients managed in specialised versus non-specialised centres.比较在专门中心和非专门中心管理的ILD 患者的结局。
Respir Res. 2022 Aug 27;23(1):220. doi: 10.1186/s12931-022-02143-1.
2
Diagnostic delay in IPF impacts progression-free survival, quality of life and hospitalisation rates.特发性肺纤维化(IPF)的诊断延迟会影响无进展生存期、生活质量和住院率。
BMJ Open Respir Res. 2022 Jul;9(1). doi: 10.1136/bmjresp-2022-001276.
3
Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.
特发性肺纤维化(更新版)和成人进展性肺纤维化:美国胸科学会/欧洲呼吸学会/日本呼吸学会/拉丁美洲胸科学会临床实践指南。
Am J Respir Crit Care Med. 2022 May 1;205(9):e18-e47. doi: 10.1164/rccm.202202-0399ST.
4
Nationwide cloud-based integrated database of idiopathic interstitial pneumonias for multidisciplinary discussion.全国性特发性间质性肺炎的基于云的综合数据库,用于多学科讨论。
Eur Respir J. 2019 May 18;53(5). doi: 10.1183/13993003.02243-2018. Print 2019 May.
5
Idiopathic interstitial pneumonias: review of the latest American Thoracic Society/European Respiratory Society classification.特发性间质性肺炎:美国胸科学会/欧洲呼吸学会最新分类综述
Radiol Bras. 2018 Sep-Oct;51(5):321-327. doi: 10.1590/0100-3984.2016.0134.
6
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.特发性肺纤维化诊断。美国胸科学会/欧洲呼吸学会/日本呼吸学会/拉丁美洲胸科学会临床实践指南。
Am J Respir Crit Care Med. 2018 Sep 1;198(5):e44-e68. doi: 10.1164/rccm.201807-1255ST.
7
Identifying Barriers to Idiopathic Pulmonary Fibrosis Treatment: A Survey of Patient and Physician Views.确定特发性肺纤维化治疗障碍:患者和医生观点调查。
Respiration. 2018;96(6):514-524. doi: 10.1159/000490667. Epub 2018 Aug 16.
8
Barriers to timely diagnosis of interstitial lung disease in the real world: the INTENSITY survey.真实世界中特发性肺纤维化及时诊断的障碍:INTENSITY 调查。
BMC Pulm Med. 2018 Jan 17;18(1):9. doi: 10.1186/s12890-017-0560-x.
9
Nintedanib in patients with idiopathic pulmonary fibrosis and preserved lung volume.尼达尼布用于特发性肺纤维化且肺容积保留患者。
Thorax. 2017 Apr;72(4):340-346. doi: 10.1136/thoraxjnl-2016-208710. Epub 2016 Sep 26.
10
An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias.美国胸科学会/欧洲呼吸学会官方声明:特发性间质性肺炎的国际多学科分类的更新。
Am J Respir Crit Care Med. 2013 Sep 15;188(6):733-48. doi: 10.1164/rccm.201308-1483ST.